Advanced search
Instruments
| Name | Stock exchange | Average volume | Price | Type | ||
|---|---|---|---|---|---|---|
| EASY FIELD CORPORATION | 6425 | Taipei Exchange | 2,559,667 |
79.1
TWD
 | Stock | |
| DEEP FIELD TECHNOLOGIES, INC. | DPFD | OTC Markets | 0 |
0.000001
USD
| Stock | |
| LEFT FIELD CAPITAL CORP. | LFC.P | Toronto S.E. | - |
0.15
CAD
| Stock | |
| ROCK FIELD CO.,LTD. | 2910 | Japan Exchange | 119,077 |
1,477
JPY
| Stock | |
| FIELD SOLUTIONS HOLDINGS LIMITED | FSG | Australian S.E. +1 Other | 229,391 |
0.025
AUD
| Stock | |
| FIELD SOLUTIONS HOLDINGS LIMITED | FSGHF | OTC Markets | - | - USD
| ||
| DOUGLAS AG | DOU | Deutsche Boerse AG +4 Other | - |
20.02
EUR
| Stock | |
| DOUGLAS AG | DOU | Wiener Boerse | - |
19.83
EUR
| ||
| DOUGLAS AG | DOU | Frankfurt | 44,344 |
19.95
EUR
| ||
| DOUGLAS AG | DOU | BOERSE MUENCHEN | - |
19.91
EUR
| ||
| DOUGLAS AG | DOU | Börse Stuttgart | 266 |
20.02
EUR
| ||
| LEFT FIELD PRINTING GROUP LIMITED | 1540 | Hong Kong S.E. | 422,840 |
0.495
HKD
| Stock | |
| RICHLY FIELD CHINA DEVELOPMENT LIMITED | 313 | Hong Kong S.E. | 11,339,445 |
0.013
HKD
| Stock | |
| TRACK & FIELD CO S.A. | TFCO4 | Sao Paulo | 180,836 |
12.06
BRL
| Stock | |
| FIELD TRIP HEALTH & WELLNESS LTD. | FTHW | Toronto S.E. +1 Other | 85,763 |
0.055
USD
| Stock | |
| FIELD TRIP HEALTH & WELLNESS LTD. | FTHW.H | Toronto S.E. | - | - CAD
|
News (5181)
Companies (2728)
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunolog ...
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunolog ...
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunolog ...
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunolog ...
Petroleo Brasileiro S.A.-Petrobras specializes in the oil, natural gas and energy industry. The Company is engaged in prospecting, drilling, refining, processing, trading and transporting crude oil from producing onshore and offshore oil fields and from s ...
Petroleo Brasileiro S.A.-Petrobras specializes in the oil, natural gas and energy industry. The Company is engaged in prospecting, drilling, refining, processing, trading and transporting crude oil from producing onshore and offshore oil fields and from s ...
Petroleo Brasileiro S.A.-Petrobras specializes in the oil, natural gas and energy industry. The Company is engaged in prospecting, drilling, refining, processing, trading and transporting crude oil from producing onshore and offshore oil fields and from s ...
Petroleo Brasileiro S.A.-Petrobras specializes in the oil, natural gas and energy industry. The Company is engaged in prospecting, drilling, refining, processing, trading and transporting crude oil from producing onshore and offshore oil fields and from s ...
Petroleo Brasileiro S.A.-Petrobras specializes in the oil, natural gas and energy industry. The Company is engaged in prospecting, drilling, refining, processing, trading and transporting crude oil from producing onshore and offshore oil fields and from s ...
VINCI is the world leader in construction, concessions and related services. Net sales (including intragroup) break down by activity as follows: - design and construction of infrastructure (44.7%; VINCI Construction): primarily in the fields of building, ...
Insiders
Douglas Field worked as Vice President-Production at Star Phoenix Group Ltd.
before obtaining a doctorate degree from the University of Leeds.
Douglas M.
Fieldhouse is the founder and Chairman of Vesta Corp., which was founded in 1995.
He is currently a Director at Facteus, Inc., a Director at Shield Compliance LLC, and a Venture Partner at Elevate Management LLC.
Mr. Fieldhouse completed his undergraduate degree at Antioch College.
Kenneth E.
Field is the founder of Greenfield Global, Inc. which was founded in 1989, where he holds the title of Chairman since 2012.
He is currently a Member of the Business Council of Canada.
Mr. Field's former positions include President & Chief Executive Officer at Bramalea Ltd.
from 1970 to 1980 and Director at United Trust Co.
Edward L.
Field served as President & CEO of Inologic, Inc. from 2004-2004.
He was the Chief Business Officer & Executive Vice President of Aldagen, Inc. from 2010-2012.
He was also the Chief Operating Officer of Nuo Therapeutics, Inc. from 2012-2014.
In addition, he served as President of Molecumetics Ltd.
from 2002-2002.
From 2015-2017, he was the President-DISC Division of BioRestorative Therapies, Inc. Mr. Field received his undergraduate degree from Duke University and his MBA from the University of Virginia Darden School of Business.
No results for this search
- Stock Market
- Advanced search
- Douglas Field